Brave Warrior Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $631K | Sell |
1,333
-2,590
| -66% | -$1.3M | 0.02% | 25 |
|
|
2025
Q4 | $1.83M | Hold |
3,923
| – | – | 0.04% | 18 |
|
|
2025
Q3 | $1.67M | Hold |
3,923
| – | – | 0.04% | 20 |
|
|
2025
Q2 | $1.5M | Buy |
3,923
+2,000
| +104% | +$721K | 0.03% | 19 |
|
|
2025
Q1 | $664K | Sell |
1,923
-1,450
| -43% | -$466K | 0.02% | 23 |
|
|
2024
Q4 | $1.01M | Hold |
3,373
| – | – | 0.03% | 18 |
|
|
2024
Q3 | $1.37M | Sell |
3,373
-500
| -13% | -$183K | 0.03% | 17 |
|
|
2024
Q2 | $1.24M | Hold |
3,873
| – | – | 0.03% | 17 |
|
|
2024
Q1 | $1.29M | Hold |
3,873
| – | – | 0.03% | 19 |
|
|
2023
Q4 | $1.05M | Buy |
3,873
+2,500
| +182% | +$618K | 0.03% | 19 |
|
|
2023
Q3 | $338K | Hold |
1,373
| – | – | 0.01% | 29 |
|
|
2023
Q2 | $417K | Sell |
1,373
-37,279
| -96% | -$10.4M | 0.01% | 24 |
|
|
2023
Q1 | $10.2M | Sell |
38,652
-376,362
| -91% | -$95.6M | 0.32% | 16 |
|
|
2022
Q4 | $99.6M | Sell |
415,014
-5,857
| -1% | -$1.31M | 3.14% | 12 |
|
|
2022
Q3 | $77.4M | Buy |
420,871
+695
| +0.2% | +$138K | 2.67% | 12 |
|
|
2022
Q2 | $70.6M | Sell |
420,176
-202,662
| -33% | -$43.5M | 2.42% | 12 |
|
|
2022
Q1 | $156M | Buy |
622,838
+14,441
| +2% | +$3.63M | 4.6% | 10 |
|
|
2021
Q4 | $156M | Sell |
608,397
-10,990
| -2% | -$2.69M | 4.98% | 10 |
|
|
2021
Q3 | $150M | Sell |
619,387
-162,849
| -21% | -$39.8M | 5.26% | 10 |
|
|
2021
Q2 | $162M | Sell |
782,236
-579,119
| -43% | -$118M | 5.55% | 10 |
|
|
2021
Q1 | $256M | Sell |
1,361,355
-260,821
| -16% | -$46M | 8.37% | 6 |
|
|
2020
Q4 | $267M | Sell |
1,622,176
-15,596
| -1% | -$2.28M | 9.81% | 4 |
|
|
2020
Q3 | $204M | Sell |
1,637,772
-27,023
| -2% | -$3.34M | 9.11% | 5 |
|
|
2020
Q2 | $162M | Buy |
1,664,795
+282,852
| +20% | +$29.4M | 8.03% | 6 |
|
|
2020
Q1 | $124M | Buy |
+1,381,943
| New | +$179M | 7.15% | 8 |
|
|
2018
Q4 | – | Sell |
-3,896
| Closed | -$542K | – | 23 |
|
|
2018
Q3 | $542K | Sell |
3,896
-2,706,488
| -100% | -$337M | 0.02% | 17 |
|
|
2018
Q2 | $278M | Sell |
2,710,384
-11,974
| -0.4% | -$1.21M | 11.39% | 4 |
|
|
2018
Q1 | $264M | Sell |
2,722,358
-183,419
| -6% | -$17.8M | 11.6% | 4 |
|
|
2017
Q4 | $255M | Sell |
2,905,777
-12,496
| -0.4% | -$1M | 10.88% | 3 |
|
|
2017
Q3 | $232M | Sell |
2,918,273
-162,074
| -5% | -$13M | 11.24% | 3 |
|
|
2017
Q2 | $269M | Sell |
3,080,347
-17,636
| -0.6% | -$1.49M | 11.87% | 2 |
|
|
2017
Q1 | $276M | Sell |
3,097,983
-519,768
| -14% | -$43.3M | 13.16% | 2 |
|
|
2016
Q4 | $268M | Buy |
3,617,751
+1,119,201
| +45% | +$83.8M | 12.77% | 2 |
|
|
2016
Q3 | $189M | Buy |
+2,498,550
| New | +$191M | 9.14% | 5 |
|
Other funds holding HCA
VCM
VPM
Brave Warrior Advisors's HCA Position: Q1 2026 in Review
Brave Warrior Advisors reduced its HCA Healthcare (HCA) stake by 66% in Q1 2026, selling an estimated $1.3M and leaving 1,333 shares worth $631K. The position accounts for 0.02% of the portfolio, ranked #25.
Brave Warrior Advisors first reported a position in HCA in Q3 2016 and has held it in 34 quarters since. The position peaked at $278M in Q2 2018. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Brave Warrior Advisors held 1,333 shares of HCA Healthcare worth $631K as of Q1 2026.
- Brave Warrior Advisors sold 2,590 HCA Healthcare shares in Q1 2026, an estimated $1.3M.
- HCA Healthcare made up 0.02% of Brave Warrior Advisors's portfolio in Q1 2026, its #25 holding.
- Brave Warrior Advisors first reported a position in HCA Healthcare in Q3 2016 and has held it in 34 quarters since.
- Brave Warrior Advisors's HCA Healthcare position peaked at $278M in Q2 2018.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Brave Warrior Advisors's 13F filing for Q1 2026, filed 15 May 2026.